Preferential vasoconstriction to cysteinyl leukotrienes in the human saphenous vein compared with the internal mammary artery. Implications for graft performance.
BACKGROUND
Platelet aggregation with the release of their vasoactive mediators is an important factor contributing to the patency of coronary bypass grafts. However, the role of leukocyte-derived mediators on graft performance is unclear. Leukotrienes (LTs) are proinflammatory mediators released from a variety of leukocytes that possess both vasoactive and mitogenic properties. We have therefore compared the effects of the cysteinyl LTs (C4, D4, and E4) on the human saphenous vein (SV) and human internal mammary artery (IMA).


RESULTS
Human SVs from 43 patients (mean age, 58 years) and IMAs from 33 patients (mean age, 57 years) were obtained from individuals undergoing coronary artery bypass surgery for coronary artery disease. The samples were set up in organ baths to record changes in vessel wall tension. In undistended SVs the cysteinyl LTs elicited concentration-dependent contractions. The Emax for LTE4 (4.23 +/- 1.0 mN; n = 6) was significantly less than that observed with either LTC4 (25.7 +/- 4.01 mN; n = 7; P < .001) or LTD4 (26.19 +/- 3.16 mN; n = 7; P < .001). In addition, the LTD4 receptor antagonist ICI 198615 (30 nmol/L) significantly inhibited the LTD4 concentration-response curve but not the LTC4 responses. Furthermore, treatment of the SV with acivicin (0.05 mmol/L), a gamma-glutamyl transpeptidase inhibitor, caused a significant rightward displacement of the LTC4 concentration-response curve. In contrast, LTC4 and LTD4 produced a response in IMAs from only 3 of 29 patients. LTC4 and LTD4 produced small contractions, of which the maximum responses were 3.28 +/- 1.92 mN (n = 5) and 3.12 +/- 1.38 mN (n = 5). LTE4 produced no responses in the IMA. Experiments in which the SV was pretreated with L-NG-monomethyl-L-arginine (L-NMMA; 10(-4) mol/L) or indomethacin (10(-5) mol/L) or was denuded of endothelium had no significant effect on the Emax values for LTE4. Also, the IMA remained unresponsive to cysteinyl leukotrienes after treatment with L-NMMA or indomethacin or endothelium removal. In vitro autoradiography localized specific [3H]-LTC4 and [3H]-LTD4 binding sites (putative receptors) to the smooth muscle cells of both SV and IMA, with greater binding to the SV.


CONCLUSIONS
Our data show that there is a preferential contraction to LTs in SV compared with IMA. This difference in smooth muscle cell reactivity to the cysteinyl LTs suggests that endogenous LT production from circulating or infiltrating leukocytes may be an important factor contributing to graft function.
Allen
S P
SP
Department of Cardiac Surgery, Harefield Hospital, Middlesex, UK.
Chester
A H
AH
Dashwood
M R
MR
Tadjkarimi
S
S
Piper
P J
PJ
Yacoub
M H
MH
D000328:Adult; D000368:Aged; D001345:Autoradiography; D001807:Blood Vessel Prosthesis; D004730:Endothelium, Vascular / Q000502:physiology; D006801:Humans; D007191:Indazoles / Q000494:pharmacology; D017999:Leukotriene E4 / Q000494:pharmacology; D015289:Leukotrienes / Q000493:pharmacokinetics / Q000494:pharmacology*; D008323:Mammary Arteries / Q000187:drug effects* / Q000378:metabolism; D008875:Middle Aged; D012146:Rest; D013189:SRS-A / Q000037:antagonists & inhibitors; D012501:Saphenous Vein / Q000187:drug effects* / Q000378:metabolism; D014661:Vasoconstriction; D014666:Vasomotor System / Q000187:drug effects
D007191:Indazoles; D015289:Leukotrienes; D013189:SRS-A; C054217:ICI 198615; D017999:Leukotriene E4